Accessibility Menu
 
Spencer Pharmaceutical logo

Spencer Pharmaceutical

(OTC) SPPH

Current Price$0.00
Market Cap$300
Since IPO (2009)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Spencer Pharmaceutical Financials at a Glance

Market Cap

$300

Revenue (TTM)

$670.21K

Net Income (TTM)

$1.24M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

12.78 (High)

Price

$0.00

Volume

6,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

SPPH News

No articles available.

SPPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spencer Pharmaceutical

Industry

Biotechnology

Headquarters

Boston, US

SPPH Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

22%

Return on Assets

-20%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$300.00

Shares Outstanding

294.36M

Volume

6.50K

Short Interest

0.00%

Avg. Volume

3.56K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$862.54K

EBITDA

$862.54K

Operating Cash Flow

$769.51K

Capital Expenditure

$0.00

Free Cash Flow

$769.51K

Cash & ST Invst.

$21.09K

Total Debt

$154.26K

Spencer Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2004YOY CHG

Revenue

$670.21K

N/A

Gross Profit

$90.08K

N/A

Gross Margin

13.44%

N/A

Market Cap

$300.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$509.69K

-278.1%

EBITDA

$460.66K

-250.8%

Quarterly Fundamentals

Name
Q1 2004YOY CHG

Net Cash

$538.61K

-717.0%

Accounts Receivable

$644.38K

+214693.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$541.45K

N/A

Return on Assets

-20.35%

N/A

Return on Invested Capital

22.35%

N/A

Free Cash Flow

$82.67K

+61.9%

Operating Cash Flow

$82.67K

+61.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OPGXOptigenex Inc.
$0.00+0.00%
MEDVFMedivolve Inc.
$0.00+0.00%
PXYNPraxsyn Corporation
$0.00+0.00%
LRDSFLords & Company Worldwide Holdings Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
NVDANvidia
$172.70-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%

Questions About SPPH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.